
WAY-169916
CAS No. 669764-18-5
WAY-169916( —— )
Catalog No. M24682 CAS No. 669764-18-5
WAY-169916 is a pathway-selective inhibitor of estrogen receptor (ER).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 87 | In Stock |
![]() ![]() |
10MG | 147 | In Stock |
![]() ![]() |
25MG | 312 | In Stock |
![]() ![]() |
50MG | 520 | In Stock |
![]() ![]() |
100MG | 750 | In Stock |
![]() ![]() |
500MG | 1521 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameWAY-169916
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-169916 is a pathway-selective inhibitor of estrogen receptor (ER).
-
DescriptionWAY-169916 is a pathway-selective inhibitor of estrogen receptor (ER). It acts by inhibiting NF-kB transcriptional activity but being devoid of conventional estrogenic activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number669764-18-5
-
Formula Weight334.29
-
Molecular FormulaC17H13F3N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC=CCn(c1c(C(F)(F)F)cccc11)nc1-c(ccc(O)c1)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu Z, et al. Synthesis of 1H-indazoles from N-tosylhydrazones and nitroaromatic compounds. Chem Commun (Camb). 2014 May 21;50(39):5061-3.
molnova catalog



related products
-
Grape Seed Extract
Grape Seed Extract is exudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (bioflavonoids and polyphenols) credited with important medicinal properties.
-
Asatone
Asatone, an active component isolated from Radix et Rhizoma Asari, has an anti-inflammatory effect via activation of NF-κB and downregulation of p-MAPK (ERK, JNK, and p38) pathways.
-
NF-κB/MAPK-IN-1
NF-κB/MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition of LPS-induced activation of iNOS, COX-2, ERΚ and P38.